Tuesday, September 20, 2005

FDA says no to COX-2 injectable proposed by Pfizer

From various sources including the FDA's websites:

The Food and Drug Administration issued a non-approvable letter for parecoxib sodium, an injectable COX-2 inhibitor. Parecoxib sodium is marketed by Pfizer under the brand name Dynastat.

It is to be administered for short periods of time under the supervision of a health-care professional.